Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Neurobiology

ISSN Print: 0892-0915
ISSN Online: 2375-0014

Archives: Volume 10, 1996 to Volume 20, 2008

Critical Reviews™ in Neurobiology

DOI: 10.1615/CritRevNeurobiol.v15.i2.10
30 pages

Regulation of Cannabinoid CB1 Receptors in the Central Nervous System by Chronic Cannabinoids

Laura J. Sim-Selley
Department of Pharmacology & Toxicology and Institute for Drug & Alcohol Studies, Virginia Commonwealth University Medical College of Virginia, Richmond, Virginia, USA


Marijuana produces a number of characteristic behaviors in humans and animals, including memory impairment, antinociception, and locomotor and psychoactive effects. However, tolerance and dependence to cannabinoids develops after chronic use, as demonstrated both clinically and in animal models. The potential therapeutic benefits of certain cannabinoid-mediated effects, as well as the use of marijuana for its psychoactive properties, has raised interest in understanding the cellular adaptations produced by chronic administration of this class of drugs. The primary active constituent of marijuana, delta9-tetrahydrohydrocannabinol (THC), binds to specific G-protein-coupled receptors. The central nervous system (CNS) effects of THC are mediated by CB1 receptors, which couple primarily to inhibitory G-proteins. High levels of CB1 receptors are found in the basal ganglia, hippocampus, cortex, and cerebellum, consistent with the profile of behavioral effects. Studies over the past decade have determined that CB1 receptors undergo downregulation and desensitization following chronic administration of THC or synthetic cannabinoid agonists. In general, these adaptations are regionally widespread and of considerable magnitude, and are thought to contribute to tolerance to cannabinoid- mediated behavioral effects. Adaptation at the effector level has been more difficult to characterize, although it appears that alterations in cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA) activity may be particularly important in cannabinoid dependence. A striking characteristic of CB1 receptor adaptation is the region dependence of the magnitude and rate of development of downregulation and desensitization. These regional differences may provide interesting insights into the mechanisms of CB1 receptors receptor signaling in different brain regions. Moreover, region-specific adaptations in CB1 receptors following chronic cannabinoid administration may produce differential adaptations at the in vivo level.

Articles with similar content:

Cerebellar-Dependent Learning as a Neurobehavioral Index of the Cannabinoid System
Critical Reviews™ in Neurobiology, Vol.19, 2007, issue 1
Patrick D. Skosnik, Chad R. Edwards
GABA Physiology: Modulation by Benzodiazepines and Hormones
Critical Reviews™ in Neurobiology, Vol.10, 1996, issue 1
Marlene A. Wilson
The Amygdala: Corticotropin-Releasing Factor, Steroids, and Stress
Critical Reviews™ in Neurobiology, Vol.10, 1996, issue 2
Thackery S. Gray, Elena W. Bingaman
Cannabinoids and Reward: Interactions with the Opioid System
Critical Reviews™ in Neurobiology, Vol.16, 2004, issue 1&2
Walter Fratta, Serena Deiana, Maria S. Spano, Gregorio Cossu, Liana Fattore, Paola Fadda, Maria Scherma
Adaptations in Adenosine Signaling in Drug Dependence: Therapeutic Implications
Critical Reviews™ in Neurobiology, Vol.15, 2003, issue 3&4
Macdonald J. Christie, Stephen P. Hack